COPD Trial, Recruiting (NCT06967324)

COPD Trial, Recruiting NCT06967324 Sponsor: Copenhagen University Hospital, Hvidovre Condition: COPD

Printed from Voxsanity (voxsanity.com.au) — NCT06967324 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Copd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with COPD (a long-term lung condition that makes breathing difficult)
People who have had a flare-up (worsening of symptoms) of their COPD at least once in the past year
People who live in Høje Taastrup or Copenhagen
People who are cognitively able to participate (able to think and understand clearly enough to take part)
People who score at certain levels on a quality-of-life questionnaire called the ICECAP-SCM, with specific score thresholds across seven areas (confirm with trial site for exact scoring details)

Who may not be able to join:

People who have dementia
People who have a psychotic condition
People who have a substance abuse problem
People who have a hearing or speech impairment that would affect their ability to participate
People who have cancer
People who are already receiving specialised palliative care or a similar type of support program
People who are in the final stage of life and considered to be imminently dying

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kirstine Benthien, Ph.d., Copenhagen University Hospital, Hvidovre

Phone: +45 24 34 21 35

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06967324

Sponsor: Copenhagen University Hospital, Hvidovre

Phase: Not Applicable

Status: Recruiting

Condition: COPD

Trial contact: +45 24 34 21 35

More information: https://clinicaltrials.gov/study/NCT06967324

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with COPD (a long-term lung condition that makes breathing difficult)
People who have had a flare-up (worsening of symptoms) of their COPD at least once in the past year
People who live in Høje Taastrup or Copenhagen
People who are cognitively able to participate (able to think and understand clearly enough to take part)
People who score at certain levels on a quality-of-life questionnaire called the ICECAP-SCM, with specific score thresholds across seven areas (confirm with trial site for exact scoring details)

Who may not be able to join:

People who have dementia
People who have a psychotic condition
People who have a substance abuse problem
People who have a hearing or speech impairment that would affect their ability to participate
People who have cancer
People who are already receiving specialised palliative care or a similar type of support program
People who are in the final stage of life and considered to be imminently dying

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Copenhagen University Hospital, Hvidovre

Registry

ClinicalTrials.gov

Start date

7 August 2025

Est. completion

31 December 2026

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

ICECAP-SCM

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov